Skip to main content
. 2012 Apr 6;90(4):648–660. doi: 10.1016/j.ajhg.2012.02.023

Table 1.

SLE Risk Loci Surpassing the Genome-wide Significance Thresholda

Chr SNP Locus Allelesb European (3,562 Cases/3,491 Controls)
African American (1,527 Cases/1,811 Controls)
Asian (1,265 Cases/1,260 Controls)
Meta
Test of Heterogeneity
pGWA scanc ORGWA scan (95% Cl) pREP ORREP (95% Cl) pMETA-Euro p OR (95% Cl) p OR (95% Cl) pMETA-ALLd pQe I2
3 rs1132200 TMEM39A G/A 1.65 × 10−3 0.72 (0.59–0.88) 2.37 × 10−4 0.83 (0.76–0.92) 1.81 × 10−6 6.92 × 10−2 0.75 (0.56–1.02) 1.66 × 10−3 0.73 (0.59–0.89) 8.62 × 10−9 0.450 0.0%
16 rs11644034 IRF8 G/A 2.29 × 10−3 0.66 (0.54–0.79) 2.36 × 10−8 0.78 (0.71–0.85) 2.08 × 10−10 5.10 × 10−1 0.95 (0.81–1.11) 2.63 × 10−2 0.79 (0.65–0.97) 2.72 × 10−9 0.016 61.5%
16 rs11648084 IRF8 G/A 5.99 × 10−4 0.76 (0.65–0.89) 9.35 × 10−7 0.83 (0.77–0.89) 2.34 × 10−9 6.33 × 10−2 0.90 (0.81–1.01) 7.52 × 10−1 1.02 (0.91–1.14) 7.00 × 10−7 0.001 74.0%
17 rs9913957 IKZF3 A/G 7.87 × 10−3 1.75 (1.27–2.41) 5.14 × 10−4 1.38 (1.15–1.66) 1.38 × 10−5 1.07 × 10−2 1.22 (1.05–1.41) 1.39 × 10−8 0.105 45.1%
17 rs8076347 IKZF3 C/A 3.07 × 10−3 1.93 (1.41–2.62) 3.04 × 10−3 1.32 (1.10–1.58) 4.75 × 10−5 2.19 × 10−3 1.20 (1.07–1.34) 3.01 × 10−8 0.047 55.4%
17 rs8079075 IKZF3 A/G 1.47 × 10−3 1.90 (1.39–2.59) 5.08 × 10−4 1.39 (1.16–1.68) 3.81 × 10−6 2.62 × 10−3 1.26 (1.08–1.46) 4.83 × 10−9 0.201 31.3%
17 rs1453560 ZPBP2 A/C 7.81 × 10−4 1.92 (1.41–2.61) 6.42 × 10−4 1.37 (1.14–1.64) 3.21 × 10−6 4.86 × 10−4 1.23 (1.09–1.37) 3.48 × 10−10 0.097 46.4%

The following abbreviations are used: Chr, chromosome; OR, odds ratio; GWA, genome-wide association; REP, replication; and CI, confidence interval.

a

Table S7 contains results for all populations evaluated within this study.

b

Major/minor alleles.

c

Result of GWA scan was previously reported in Graham et al.1

d

Data were combined for all racial groups genotyped within our study that passed quality control.

e

Cochran's Q test statistic.